• Reference Citation Analysis
  • v
  • v
  • Find an Article
  • Find an Author
Download
For: Emery P, Bingham C, Burmester GR, Bykerk V, Furst D, Mariette X, van der Heijde D, van Vollenhoven R, VanLunen B, Ecoffet C, Cioffi C, Weinblatt M. OP0227 A Randomized Double-Blind Treatment Strategy Study Evaluating Continuation or Reduced-Frequency Dosing of Certolizumab Pegol versus Withdrawal To Maintain Low Disease Activity in Early RA Patients (C-Early Period 2). Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.1468] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Number Cited by Other Article(s)
1
Emery P, Bingham CO, Burmester GR, Bykerk VP, Furst DE, Mariette X, Heijde DVD, Vollenhoven RV, Arendt C, Mountian I, Purcaru O, Tatla D, VanLunen B, Weinblatt ME. Response to: 'Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!' by Boers. Ann Rheum Dis 2016;75:e69. [PMID: 27519773 DOI: 10.1136/annrheumdis-2016-210083] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2016] [Accepted: 07/03/2016] [Indexed: 11/03/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA